Trial Profile
A prospective, single-center study to evaluate the serum miRNA levels of infliximab during induction therapy in patients with Crohn's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Pharmacokinetics; Therapeutic Use
- 14 Dec 2015 New trial record